Kim P. Kamdar
Investing Profile
Domain Associates thesis
FOUNDED IN 1985 FOUNDED IN 1985 FOUNDED IN 1985 FOUNDED IN 1985 INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECH INVESTMENT MANAGER OF 9 SUBSEQUENT BIOTECH VC FUNDS $2.8 Billion assets managed VC funding of 194 biopharm, device and diagnostic companies 90 IPOs 110 M&A events $190 Billion market cap of funded companies Click for More Info and Portfolio Team Members James Blair, Partner Brian Dovey, Partner (In Memorium 2023) Brian Halak, Partner Kim Kamdar, Partner Jesse Treu, Partner Emeritus Nicole Vitullo, Partner Kathleen Schoemaker, Partner and CFO (In Memorium 2016) Lisa Krae
Sector and stage focus
- Series B: BioTech, Pharmaceuticals, Health & Hospital Services, Health IT
- Series A: BioTech, Pharmaceuticals, Health IT, Health & Hospital Services
- general: Diverse Investors, Female Investors, Los Angeles / Southern California
Recent investments by Kim P. Kamdar
Kim P. Kamdar has 6 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| ROX Medical | Series D | Sep 2012 | $6M |
| Sera Prognostics | Series B | Nov 2014 | $5M |
| Sonexa Therapeutics | Series A | Jan 2008 | $30M |
| Evofem Biosciences | Series C | Feb 2014 | $8M |
| Syndax Pharmaceuticals | Series C | Aug 2015 | $80M |
| Epic Sciences | Series D | Apr 2017 | $40M |
Frequent co-investors
Kim P. Kamdar has co-invested with: Dennis Podlesak, Steven St. Peter, Dan Janney, Debra K. Liebert, Louis Bock.
Is Kim P. Kamdar a fit for your round?
Upload your pitch deck and see whether Kim P. Kamdar appears in your top 20 matches.
Find investors for your deck